PDGFRα (D842I) Assay Kit
Platelet-derived growth factor receptor A or PDGFRα has been implicated in regulation of cell growth and survival, apoptosis, and differentiation. It has been identified as a potential target in eosinophilic leukemia cancer, inflammatory breast cancer, and gastrointestinal stromal tumors. The D842 mutation is found in gastrointestinal stromal tumors and is associated with resistance to tyrosine kinase inhibitors. The PDGFRα (D842I) Assay Kit is designed to measure PDGFRα (D842I) activity for screening and profiling applications using Kinase-Glo® MAX as a detection reagent.
Need us to run inhibitor screens or profile your compounds against PDGFRα (D842I)? Check out our Kinase Screening Services.
This product has been cited 2 times.
Kinase-Glo MAX (Promega #V6071)
Dithiothreitol (DTT, 1 M; optional)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator
Catalog # |
Reagent |
Amount |
Storage |
|
-80°C |
Avoid multiple freeze/ thaw cycles! |
|||
1.5 ml |
-20°C |
|||
100 µl |
-20°C |
|||
Protein Tyrosine Kinase Substrate (Poly-Glu,Tyr 4:1) (10 mg/ml) |
100 µl |
-20°C |
||
79696 |
96-well plate, white |
1 |
RT |
|
1. Evans, E., et al. A Precision Therapy Against Cancers Driven by KIT/PDGFRA Mutations; 2017, Science Translational Medicine Nov; 9(414): 1690.
2. Joglekar-Javadekar, M., et al. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia. 2017 Jul; 19(7):564-573.
3. Corless, C.L., et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol. 2005 Aug 10; 23(23):5357-64.